4/A//SEC Filing
Morgan Adam 4/A
Accession 0000950170-25-013780
CIK 0000818033other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:37 PM ET
Size
8.5 KB
Accession
0000950170-25-013780
Insider Transaction Report
Form 4/AAmended
Morgan Adam
Director
Transactions
- Award
Common Stock
2025-01-31+17,950→ 69,777 total - Award
Stock Option (Right to Buy)
2025-01-31+35,900→ 35,900 totalExercise: $1.70Exp: 2035-01-31→ Common Stock (35,900 underlying)
Holdings
- 6,986,744(indirect: By Velan Capital Master Fund LP)
Common Stock
Footnotes (3)
- [F1]The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Securities owned directly by Velan Capital Master Fund LP ("Velan Master"). Mr. Morgan, as a managing member of each of Velan Capital Holdings LLC, the general partner of Velan Master, and Velan Capital Management LLC, the general partner of the investment manager of Velan Master, may be deemed to beneficially own the securities owned directly by Velan Master. Mr. Morgan disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Morgan is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001964335
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:37 PM ET
- Size
- 8.5 KB